Overview
Ovid Therapeutics is a biopharmaceutical company developing therapeutic programs for rare neurological disorders[2]. Founded in 2014[3], the company is headquartered in New York at Hudson Commons, 441 9th Avenue[1].
The company's own site places it in New York: Website states 'Our Headquarters' at 'Hudson Commons 441 9th Avenue New York, NY 10001'. [1]
Business address: 441 9th Ave, New York, New York, 10001. [4]
Financials
TickerNASDAQ: OVIDMarket value$414.3MShare price2.38 USD
2026-102.38 USD-29% since 2021
2021-11low 0 · high 42026-10
Market data, not a filing. Read 2026-10-02.
Revenue as reported
Key people
Alumni
Something wrong or missing? Send an update. Fixed within 24 hours.